Original Research
Published on 12 Feb 2026
A composite biomarker based on early dynamic changes in lactate dehydrogenase and PD-L1 expression enhances outcome prediction for immunochemotherapy in HER2-negative advanced gastric cancer
in Cancer Immunity and Immunotherapy